69 related articles for article (PubMed ID: 10515682)
21. Transplantation of human hematopoietic repopulating cells: mechanisms of regeneration and differentiation using human-mouse xenografts.
Guezguez B; Bhatia M
Curr Opin Organ Transplant; 2008 Feb; 13(1):44-52. PubMed ID: 18660706
[TBL] [Abstract][Full Text] [Related]
22. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
24. Preclinical protocol for in vivo selection of hematopoietic stem cells corrected by gene therapy in Fanconi anemia group C.
Noll M; Bateman RL; D'Andrea AD; Grompe M
Mol Ther; 2001 Jan; 3(1):14-23. PubMed ID: 11162306
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors.
Tian C; Bagley J; Forman D; Iacomini J
Gene Ther; 2006 Apr; 13(7):652-8. PubMed ID: 16341058
[TBL] [Abstract][Full Text] [Related]
26. Rho GTPases and regulation of hematopoietic stem cell localization.
Williams DA; Zheng Y; Cancelas JA
Methods Enzymol; 2008; 439():365-93. PubMed ID: 18374178
[TBL] [Abstract][Full Text] [Related]
27. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells.
Ailles L; Schmidt M; Santoni de Sio FR; Glimm H; Cavalieri S; Bruno S; Piacibello W; Von Kalle C; Naldini L
Mol Ther; 2002 Nov; 6(5):615-26. PubMed ID: 12409260
[TBL] [Abstract][Full Text] [Related]
28. Engineering mesenchymal stem cells for immunotherapy.
Jorgensen C; Djouad F; Apparailly F; Noël D
Gene Ther; 2003 May; 10(10):928-31. PubMed ID: 12732877
[TBL] [Abstract][Full Text] [Related]
29. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
[TBL] [Abstract][Full Text] [Related]
30. Transgene insertion in proximity to the c-myb gene disrupts erythroid-megakaryocytic lineage bifurcation.
Mukai HY; Motohashi H; Ohneda O; Suzuki N; Nagano M; Yamamoto M
Mol Cell Biol; 2006 Nov; 26(21):7953-65. PubMed ID: 16940183
[TBL] [Abstract][Full Text] [Related]
31. Non-myeloablative conditioning for hemopoietic stem cell transplantation--does it work?
Cheong SK; Eow GI; Leong CF
Malays J Pathol; 2002 Jun; 24(1):1-8. PubMed ID: 16329549
[TBL] [Abstract][Full Text] [Related]
32. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
[TBL] [Abstract][Full Text] [Related]
33. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
[TBL] [Abstract][Full Text] [Related]
34. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
[TBL] [Abstract][Full Text] [Related]
35. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
36. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
37. Proliferation of multipotent hematopoietic cells controlled by a truncated erythropoietin receptor transgene.
Kirby SL; Cook DN; Walton W; Smithies O
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9402-7. PubMed ID: 8790342
[TBL] [Abstract][Full Text] [Related]
38. Hematopoietic stem cells with controllable tEpoR transgenes have a competitive advantage in bone marrow transplantation.
Kirby S; Walton W; Smithies O
Blood; 2000 Jun; 95(12):3710-5. PubMed ID: 10845901
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin receptor mutations and human disease.
Gregg XT; Prchal JT
Semin Hematol; 1997 Jan; 34(1):70-6. PubMed ID: 9025165
[No Abstract] [Full Text] [Related]
40. The therapeutic potential of erythropoietin receptor transgenes.
Kirby SL
Cytokines Cell Mol Ther; 1999 Jun; 5(2):97-104. PubMed ID: 10515682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
